185 related articles for article (PubMed ID: 35771229)
21. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Wang N; Zhou X; Tang F; Wang X; Zhu X
Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
[TBL] [Abstract][Full Text] [Related]
22. H2AFX might be a prognostic biomarker for hepatocellular carcinoma.
Hu H; Zhong T; Jiang S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1684. PubMed ID: 35903980
[TBL] [Abstract][Full Text] [Related]
23. METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment.
Wang L; Peng JL
Sci Rep; 2023 Jul; 13(1):10755. PubMed ID: 37400463
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic and Therapeutic Roles of ARL-6 Gene in Hepatocellular Carcinoma.
Wang J; Che F; Zhao Y; Wei L; Chen D; Dai C; Zhang B; Zhou X; Yang B; Chen Z
Int J Med Sci; 2024; 21(2):207-218. PubMed ID: 38169538
[No Abstract] [Full Text] [Related]
25. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
26. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
Shang BB; Chen J; Wang ZG; Liu H
PeerJ; 2021; 9():e12315. PubMed ID: 34754620
[TBL] [Abstract][Full Text] [Related]
27. PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest.
Wang X; Yang J; Luo L; Li X; Zhang Y
Aging (Albany NY); 2023 May; 15(10):4122-4143. PubMed ID: 37211383
[TBL] [Abstract][Full Text] [Related]
28. Cell cycle kinases (AUKA, CDK1, PLK1) are prognostic biomarkers and correlated with tumor-infiltrating leukocytes in HBV related HCC.
Islam B; Yu HY; Duan TQ; Pan J; Li M; Zhang RQ; Masroor M; Huang JF
J Biomol Struct Dyn; 2023; 41(21):11845-11861. PubMed ID: 36634158
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
[TBL] [Abstract][Full Text] [Related]
30. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
31. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.
Matsuda Y
World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604
[TBL] [Abstract][Full Text] [Related]
33. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
[TBL] [Abstract][Full Text] [Related]
34. The role of complement in the clinical course of hepatocellular carcinoma.
Qian X; Yang Z; Gao L; Liu Y; Yan J
Immun Inflamm Dis; 2022 Mar; 10(3):e569. PubMed ID: 34813686
[TBL] [Abstract][Full Text] [Related]
35. Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration.
Nong JS; Zhou X; Liu JQ; Luo JZ; Huang JM; Xie HX; Yang KJ; Wang J; Ye XP; Peng T
Cancer Med; 2023 May; 12(9):10990-11009. PubMed ID: 36952458
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
37. Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Xu M; Liang H; Li K; Zhu S; Yao Z; Xu R; Lin N
Aging (Albany NY); 2021 Feb; 13(4):5263-5283. PubMed ID: 33535183
[TBL] [Abstract][Full Text] [Related]
38. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.
Xu J; Shen X; Zhang B; Su R; Cui M; Yan L; Cao Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34386813
[TBL] [Abstract][Full Text] [Related]
40. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
